By API User
As a prolonged heat wave grips Australia this week, the Royal Australian College of GPs (RACGP) is encouraging the public to prioritise hydration, rest indoors, and check in on people more susceptible to heat exhaustion and heat stroke. It comes following the Bureau of Meteorology warning of a multi-day heatwave covering more than half of … Continued
By API User
As a prolonged heat wave grips Australia this week, the Royal Australian College of GPs (RACGP) is encouraging the public to prioritise hydration, rest indoors, and check in on people more susceptible to heat exhaustion and heat stroke. It comes following the Bureau of Meteorology warning of a multi-day heatwave covering more than half of the country … Continued
By API User
Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 status High GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impact Results to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. … Continued
By API User
Wednesday 7 January, 2026 For immediate release Australians will suffer under extreme heat over the coming days, with the Bureau of Meteorology warning of the most significant heatwave to hit south-eastern Australia in six years. Large parts of the country are facing multi-day temperatures well above average, with dangerous heat compounding fire danger across already … Continued
By API User
The Big Bold Swim for breast cancer research kicks off in February, a perfect time to commit to those New Year fitness goals while raising vital funds for Breast Cancer Trials’ clinical trials research. While breast cancer survival rates have improved significantly in recent years, in Australia 56 people are diagnosed every day and 3,300 … Continued
By API User
6 January 2026 – Sydney, Australia | Nexsen Limited (ASX:NXN) has announced the commencement of formal engagement with the United States Food and Drug Administration (FDA) as it advances its rapid Group B Streptococcus (GBS) point-of-care diagnostic toward market entry into the world’s largest maternal health market. The Company has lodged a Pre-Submission with the … Continued
By API User
Centenary Institute researchers have achieved success in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants, securing funding for innovative work in rare genetic diseases and liver disease. A team led by Dr Chuck Bailey, Head of the Centenary Institute’s Centre for Rare Diseases and Gene Therapy, will receive $1,944,020 … Continued
By API User
Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT Technology World’s First Therapy Platform Simultaneously Solving Immune Rejection and Inheritance of Cellular Aging—The Major Hurdles of Existing Stem Cell Therapies Drastically Improving Treatment Accessibility through the New Paradigm, ‘Patient-Initiated Clinical Trial™’, which Overcomes Existing Clinical … Continued
By API User
Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Helus Pharma commences trading on Nasdaq Global Market (“Nasdaq”) and on Cboe Canada under ticker symbol: HELP Helus Pharma continues to progress its portfolio of novel serotonergic agonists (“NSAs”), with the goal … Continued
By API User
IRVINE, Calif.–BUSINESS WIRE– SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the completion of a strategic minority equity investment and the establishment of a structured collaboration framework with OrangeTwist, a leading U.S.-based MedSpa chain, … Continued
